Actively Recruiting
Genetic Testing Decision Aid
Led by Massachusetts General Hospital · Updated on 2025-08-13
350
Participants Needed
2
Research Sites
219 weeks
Total Duration
On this page
Sponsors
M
Massachusetts General Hospital
Lead Sponsor
N
National Cancer Institute (NCI)
Collaborating Sponsor
AI-Summary
What this Trial Is About
This is a randomized trial to evaluate the effectiveness of an electronic decision aid tool versus a traditional genetic counselor session for multi-gene panel testing for people with ovarian or pancreatic cancer
CONDITIONS
Official Title
Genetic Testing Decision Aid
Who Can Participate
Eligibility Criteria
You may qualify if you...
- 18 years or older
- Receiving care at Massachusetts General Hospital or Boston Medical Center
- Diagnosed with malignant epithelial ovarian carcinoma or malignant pancreatic adenocarcinoma
You will not qualify if you...
- Unable or unwilling to provide informed consent, undergo randomization, or complete study surveys
- Previous germline genetic testing
- History of hereditary pancreatitis
- Adults unable to consent or individuals who are not adults
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 2 locations
1
Massachusetts General Hospital
Boston, Massachusetts, United States, 02115
Actively Recruiting
2
Mass General at North Shore Cancer Center
Danvers, Massachusetts, United States, 01923
Actively Recruiting
Research Team
D
Daniel C. Chung, MD
CONTACT
D
Danielle A Lynch, BS
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
HEALTH_SERVICES_RESEARCH
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here